Unichem Laboratories fell 3.95% to Rs 222.60 at 13:01 IST on BSE after net profit fell 97.2% to Rs 2.06 crore on 0.1% decline in net sales to Rs 262.89 crore in Q3 December 2014 over Q3 December 2013.
The Q3 result was announced on Saturday, 17 January 2015.
Meanwhile, the S&P BSE Sensex was up 142.68 points or 0.51% at 28,264.57.
On BSE, so far 47,000 shares were traded in the counter as against average daily volume of 46,591 shares in the past one quarter.
The stock hit a high of Rs 225.90 and a low of Rs 212 so far during the day. The stock had hit a 52-week low of Rs 182 on 14 July 2014. The stock had hit a 52-week high of Rs 267.90 on 15 December 2014.
Also Read
The stock had underperformed the market over the past one month till 16 January 2015, sliding 5.81% compared with Sensex's 5.01% rise. The scrip had also underperformed the market in past one quarter, advancing 6.38% as against Sensex's 8.16% rise.
The small-cap pharmaceutical company has equity capital of Rs 18.15 crore. Face value per share is Rs 2.
Unichem Laboratories is an international, integrated, specialty pharmaceutical company.
Powered by Capital Market - Live News
